The progress made this year is setting the stage for 2026, as healthcare and clinical research work together toward a healthier future for all
Retrieved from Kumar, P., et al
Retatrutide adds a third mechanism: glucagon receptor agonism
Shorter assessment periods don't provide reliable data on whether the higher concentration truly improves outcomes
Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea Tel: +82-31-787-7035, Fax: +82-31-787-4051, E-mail: [email protected] Copyright 2024 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited